Studies have shown that inhibiting FAK, through either genetic knockdown or pharmacological inhibitors, significantly reduces tumor growth and induces apoptosis in clear cell renal cell carcinoma (ccRCC) [33]. The gene discussed is PTK2; the disease is nonpapillary renal cell carcinoma.